Combination of cetuximab with met inhibitor in control of cetuximab-resistant oral squamous cell carcinoma.
Year: 2019
Type: article
Abstract: This study demonstrates that Met/HGF expression results in OSCC resistance to cetuximab and tumor recurrence after cetuximab therapy; thus, inhibition of Met/HGF activity could restore OSCC sensitivity to cetuximab.
Source: PubMed
Authors: Hua Yang, Chuzi Mo, Yang Xun, Leyna G Liu, Wenxing Li, Jieying Guan, Jing Liu, Jianquan Wu, Anping Yang, Songguo Zheng, Dahai Liu, Fang Liu
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2980786348